A Sucker Punch at the Drug Industry (Book Review)

July/August 2003Health Affairs

Reading Time : 1 min

There is no mistaking Katharine Greider’s thesis in The Big Fix: The way Americans obtain and pay for prescription drugs is inflationary, corrupt, and broken, and it is the drug manufacturers’ fault. But for all of the problems Greider identifies, some of which may need to be addressed, it is not clear why she has singled out drug manufacturers as the guilty party. Many of the ills she describes result from a combination of U.S. consumers’ attitudes toward health care, which demonstrate a strong faith in the free market, and the payment policies of the entities that fund most of the drug purchases in this country—state and federal governments and other third-party payers such as insurance carriers, managed care organizations, and employers.

Share This Insight

Attachments

Related Services, Sectors, and Regions

© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.